Aminothiazole compounds with mono-/di-substituted benzamide are represented by the Formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable prodrugs, pharmaceutically active metabolites, and pharmaceutically acceptable salts of said metabolites are described.
These agents modulate and/or inhibit the cell proliferation and activity of protein kinases and are useful as pharmaceuticals for treating malignancies and other disorders.
具有单/双取代苯甲酰胺的
氨基
噻唑化合物由公式(I)表示,其药学上可接受的盐,药学上可接受的前药,药学上活性代谢物以及所述代谢物的药学上可接受的盐被描述。这些药物调节和/或抑制细胞增殖和蛋白激酶活性,并且可用作治疗恶性肿瘤和其他疾病的药物。